Research & Development

Targeting PAF: A New Frontier in Cancer Therapy
Research & Development Targeting PAF: A New Frontier in Cancer Therapy

In the relentless battle against cancer, a disease that continues to challenge medical science with its complexity and resilience, a promising new direction has emerged through the targeting of platelet-activating factor (PAF), a potent phospholipid mediator intricately involved in tumor

AI-Driven Natural Drug Design for Metabolic Diseases
Research & Development AI-Driven Natural Drug Design for Metabolic Diseases

In a world grappling with the escalating burden of metabolic diseases, innovative solutions are urgently needed to address conditions like type 2 diabetes, obesity, non-alcoholic fatty liver disease, and certain cancers, which collectively affect millions globally and strain healthcare systems.

Once-Weekly Insulin Icodec Cuts Hospitalizations in Trials
Research & Development Once-Weekly Insulin Icodec Cuts Hospitalizations in Trials

In a world where diabetes affects millions and places an immense strain on healthcare systems globally, a revolutionary approach to treatment has emerged from the Phase 3a ONWARDS 1–6 trials, showcasing the potential of Once-Weekly Insulin Icodec. This innovative therapy, distinct from the daily

Digital Therapy App Tested for Knee Pain Relief in Trial
Research & Development Digital Therapy App Tested for Knee Pain Relief in Trial

In a remarkable stride toward modernizing healthcare, a clinical trial is underway to evaluate MORA Cure PFP, a cutting-edge digital therapy app designed to alleviate knee pain caused by patellofemoral pain syndrome (PFP), a condition marked by discomfort around or behind the kneecap. This ailment

Can Urine Test Revolutionize Prostate Cancer Detection?
Research & Development Can Urine Test Revolutionize Prostate Cancer Detection?

Imagine a world where a simple, noninvasive test could detect prostate cancer with pinpoint accuracy, sparing countless men from the anxiety and discomfort of unnecessary biopsies, and potentially transforming the landscape of early diagnosis. Prostate cancer remains a leading cause of

Ionis Drug Tryngolza Excels in Lipid-Lowering Trials
Research & Development Ionis Drug Tryngolza Excels in Lipid-Lowering Trials

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of innovation in the industry. Today, we’re diving into the exciting developments surrounding Tryngolza, a groundbreaking lipid-lowering

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later